AI assistant
Sending…
Workhorse Group Inc. — Director's Dealing 2016
Dec 9, 2016
34980_dirs_2016-12-09_1484d69a-0d70-4478-97c8-796fa7bd9f8c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Workhorse Group Inc. (WKHS)
CIK: 0001425287
Period of Report: 2016-11-18
Reporting Person: Budde Gerald B. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-11-18 | Common Stock, $0.001 par value per share | X | 25000 | $37500 | Acquired | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-11-18 | Common Stock Purchase Warrant | $1.50 | X | 25000 | Disposed | 2017-05-28 | Common Stock, Par Value $0.001 (0) | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options | $7.01 | 2020-12-17 | Common Stock, Par Value $0.001 (50000) | 50000 | Direct |
| Stock Options | $7.21 | 2021-08-16 | Common Stock, Par Value $0.001 (10000) | 10000 | Direct |
Footnotes
F1: On November 18, 2016, the Gerald B. Budde Living Trust dated September 8, 2004 exercised a common stock purchase warrant to acquire 25,000 shares of common stock at an exercise price of $1.50 per share. Gerald Budde is the trustee of such trust.
F2: 10,000 of the options vested on December 17, 2015 and 4,000 shall vest every six (6) months thereafter on June 30 and December 31.
F3: 2,500 of the options vested on August 16, 2016 and an additional 2,500 will vest every six months thereafter.
More from Workhorse Group Inc.
Annual Report
2026
May 20
Proxy Solicitation & Information Statement
2026
May 20
Proxy Solicitation & Information Statement
2026
May 20
Interim / Quarterly Report
2026
May 14
Earnings Release
2026
May 14
Capital/Financing Update
2026
Apr 27
Regulatory Filings
2026
Apr 23
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Jan 28